Analysts Set Privia Health Group, Inc. (NASDAQ:PRVA) PT at $26.67

Shares of Privia Health Group, Inc. (NASDAQ:PRVA) have earned a consensus rating of “Buy” from the sixteen analysts that are covering the firm, Marketbeat reports. One analyst has rated the stock with a hold rating, thirteen have given a buy rating and two have assigned a strong buy rating to the company. The average 1-year price objective among analysts that have updated their coverage on the stock in the last year is $26.67.

Several equities research analysts recently commented on PRVA shares. Piper Sandler increased their price objective on Privia Health Group from $25.00 to $40.00 and gave the company an “overweight” rating in a research report on Friday, February 28th. JPMorgan Chase & Co. raised their price target on shares of Privia Health Group from $27.00 to $28.00 and gave the company an “overweight” rating in a report on Friday, November 29th. Canaccord Genuity Group boosted their price objective on shares of Privia Health Group from $29.00 to $30.00 and gave the company a “buy” rating in a report on Friday, February 28th. Needham & Company LLC restated a “buy” rating and issued a $30.00 target price on shares of Privia Health Group in a report on Friday, March 21st. Finally, Stephens reiterated an “overweight” rating and set a $26.00 target price on shares of Privia Health Group in a research note on Thursday, January 2nd.

Institutional Inflows and Outflows

A number of hedge funds have recently made changes to their positions in PRVA. First Horizon Advisors Inc. raised its stake in Privia Health Group by 53.8% during the 4th quarter. First Horizon Advisors Inc. now owns 1,807 shares of the company’s stock worth $35,000 after acquiring an additional 632 shares during the period. EverSource Wealth Advisors LLC raised its position in shares of Privia Health Group by 7,833.3% during the 4th quarter. EverSource Wealth Advisors LLC now owns 2,380 shares of the company’s stock valued at $47,000 after purchasing an additional 2,350 shares during the period. Financial Management Professionals Inc. purchased a new position in shares of Privia Health Group during the 4th quarter valued at $51,000. Quarry LP boosted its holdings in Privia Health Group by 344.6% in the 3rd quarter. Quarry LP now owns 3,268 shares of the company’s stock worth $60,000 after buying an additional 2,533 shares during the period. Finally, KBC Group NV increased its stake in Privia Health Group by 34.6% in the 3rd quarter. KBC Group NV now owns 3,385 shares of the company’s stock worth $62,000 after buying an additional 871 shares in the last quarter. 94.48% of the stock is currently owned by institutional investors.

Privia Health Group Trading Down 1.4 %

Shares of PRVA opened at $22.59 on Monday. The company has a market cap of $2.72 billion, a price-to-earnings ratio of 225.92, a P/E/G ratio of 3.47 and a beta of 0.85. The business’s fifty day simple moving average is $23.80 and its two-hundred day simple moving average is $21.16. Privia Health Group has a 12 month low of $15.92 and a 12 month high of $26.04.

Privia Health Group Company Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.